Fabrinet's Suppliers recorded an increase in sales by 17.77 % year on year in Q4 2026, sequentially sales grew by 6.11 %, Fabrinet recorded an increase in cost of sales by 45.01 % year on year, sequentially cost of sales grew by 8.2 % in Q4.
Fabrinet's Suppliers recorded an increase in sales by 17.77 % year on year in Q4 2026, sequentially sales grew by 6.11 %, Fabrinet recorded increase in cost of sales by 45.01 % year on year, sequentially cost of sales grew by 8.2 % in Q4.
The company procures a range of optical, semiconductor, mechanical, and electronic components, assemblies, and raw materials primarily through standard purchase orders rather than long-term supply agreements. It depends on sole-source suppliers for several critical materials, including some small businesses, which presents risks related to supplier financial stability and reliability. The company has encountered supply shortages due to reduced yields from suppliers and difficulties in identifying alternative sources, potentially causing delays in product manufacturing and revenue recognition. It maintains comprehensive quality management systems with certifications such as ISO 9001, ISO 14001, TL 9000, IATF 16949, ISO 13485, AS 9100, NADCAP, ISO 45001, ISO/IEC 17025, ISO 22301, ISO/IEC 27001, ISO 50001, ANSI ESD S20.20, TAPA, CTPAT, and CSR-DIW. The company complies with FDA regulations for medical device manufacturing and undergoes ongoing inspections and reviews. In the European Union, it holds required ISO certifications and is subject to periodic regulatory inspections to maintain its manufacturing service approvals.
Fabrinet's Comment on Supply Chain
The company procures a range of optical, semiconductor, mechanical, and electronic components, assemblies, and raw materials primarily through standard purchase orders rather than long-term supply agreements. It depends on sole-source suppliers for several critical materials, including some small businesses, which presents risks related to supplier financial stability and reliability. The company has encountered supply shortages due to reduced yields from suppliers and difficulties in identifying alternative sources, potentially causing delays in product manufacturing and revenue recognition. It maintains comprehensive quality management systems with certifications such as ISO 9001, ISO 14001, TL 9000, IATF 16949, ISO 13485, AS 9100, NADCAP, ISO 45001, ISO/IEC 17025, ISO 22301, ISO/IEC 27001, ISO 50001, ANSI ESD S20.20, TAPA, CTPAT, and CSR-DIW. The company complies with FDA regulations for medical device manufacturing and undergoes ongoing inspections and reviews. In the European Union, it holds required ISO certifications and is subject to periodic regulatory inspections to maintain its manufacturing service approvals.
FN's Suppliers Net Income grew by
FN's Suppliers Net margin grew in Q4 to
35.16 %
20.41 %
FN's Suppliers Net Income grew by 35.16 %
FN's Suppliers Net margin grew in Q4 to 20.41 %
Fabrinet's Suppliers Sales Growth
in Q4 2026 by Industry
Sources:
Fabrinet's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Fabrinet’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
9.88 % 